MCID: CHL013
MIFTS: 37

Cholecystolithiasis

Categories: Gastrointestinal diseases

Aliases & Classifications for Cholecystolithiasis

MalaCards integrated aliases for Cholecystolithiasis:

Name: Cholecystolithiasis 12 43 15 17 71

Classifications:



External Ids:

Disease Ontology 12 DOID:11151
MeSH 43 D041761
NCIt 49 C34443
SNOMED-CT 67 44900007
UMLS 71 C0947622

Summaries for Cholecystolithiasis

MalaCards based summary : Cholecystolithiasis is related to cholelithiasis and ascending colon cancer. An important gene associated with Cholecystolithiasis is UVRAG (UV Radiation Resistance Associated), and among its related pathways/superpathways are Wnt / Hedgehog / Notch and Hippo signaling pathway. The drugs Dopamine and Esketamine have been mentioned in the context of this disorder. Affiliated tissues include pancreas, liver and skin.

Wikipedia : 74 A gallstone is a stone formed within the gallbladder out of bile components. The term cholelithiasis may... more...

Related Diseases for Cholecystolithiasis

Diseases related to Cholecystolithiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 167)
# Related Disease Score Top Affiliating Genes
1 cholelithiasis 30.7 GPT CRP CCK
2 ascending colon cancer 30.5 UVRAG CEACAM5
3 cholangitis 30.3 GPT CRP CEACAM5
4 portal hypertension 30.2 TGFB1 GPT CCN2
5 liver cirrhosis 30.1 TGFB1 GPT CRP CCN2
6 choledocholithiasis 29.9 GPT GGTLC3 CRP CEACAM5 CCK
7 acalculous cholecystitis 29.8 GPT CRP CCK
8 suppurative cholangitis 29.8 GPT GGTLC3 CRP
9 bilirubin metabolic disorder 29.8 GPT GGTLC3 CRP
10 acute pancreatitis 29.7 GPT CRP CCK
11 acute cholangitis 29.5 GPT GGTLC3 CRP CEACAM5
12 gallbladder disease 29.1 GPT GGTLC3 CRP CEACAM5 CCK
13 gallbladder disease 1 11.7
14 cholecystitis 10.6
15 scleroderma, familial progressive 10.5 CCN2 BMP6
16 keloid disorder 10.5 TGFB1 BMP6
17 stiff skin syndrome 10.4 TGFB1 CCN2
18 kidney hypertrophy 10.4 TGFB1 CCN2
19 dupuytren contracture 10.4 TGFB1 BMP6
20 urethral stricture 10.4 TGFB1 CCN2
21 diffuse scleroderma 10.4 TGFB1 CCN2
22 autoimmune hepatitis type 1 10.4 GPT BMP6
23 laryngitis 10.4 TGFB1 CRP
24 nephrogenic systemic fibrosis 10.4 TGFB1 CCN2
25 pancreas lymphoma 10.4 GPT CEACAM5
26 pulmonary arterial hypertension associated with congenital heart disease 10.4 CRP CCN2
27 hypertrophic scars 10.4 TGFB1 BMP6
28 ocular cicatricial pemphigoid 10.4 TGFB1 CCN2
29 external ear carcinoma 10.4 CRP CEACAM5
30 sarcomatous intrahepatic cholangiocarcinoma 10.3 GPT CEACAM5
31 pericardial tuberculosis 10.3 CRP CEACAM5
32 tuberculous peritonitis 10.3 CRP CEACAM5
33 eosinophilia-myalgia syndrome 10.3 TGFB1 BMP6
34 tuberculoid leprosy 10.3 TGFB1 BMP6
35 gallbladder small cell carcinoma 10.3 CRP CEACAM5
36 emphysematous cholecystitis 10.3 GPT CRP
37 ileus 10.3
38 lymphangitis 10.3 CRP CEACAM5
39 abdominal tuberculosis 10.3 CRP CEACAM5
40 tinea unguium 10.3 GPT CRP
41 splenic abscess 10.3 GPT CRP
42 granulomatous hepatitis 10.3 GPT CRP
43 ovarian squamous cell carcinoma 10.3 CRP CEACAM5
44 heart aneurysm 10.3 GPT CRP
45 hydrops of gallbladder 10.3 GPT CRP
46 microvascular complications of diabetes 3 10.3 TGFB1 CCN2 BMP6
47 localized scleroderma 10.3 TGFB1 CCN2 BMP6
48 coronary aneurysm 10.3 GPT CRP
49 pyuria 10.2 GPT CRP
50 pulmonary fibrosis 10.2 TGFB1 CCN2 BMP6

Graphical network of the top 20 diseases related to Cholecystolithiasis:



Diseases related to Cholecystolithiasis

Symptoms & Phenotypes for Cholecystolithiasis

Drugs & Therapeutics for Cholecystolithiasis

Drugs for Cholecystolithiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 146)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
2
Esketamine Approved, Investigational Phase 4 33643-46-8
3
Droperidol Approved, Vet_approved Phase 4 548-73-2 3168
4
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
5
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
6
tannic acid Approved Phase 4 1401-55-4
7
Benzocaine Approved, Investigational Phase 4 94-09-7, 1994-09-7 2337
8
Ropivacaine Approved Phase 4 84057-95-4 71273 175805
9
Flurbiprofen Approved, Investigational Phase 4 5104-49-4 3394
10
Levobupivacaine Approved, Investigational Phase 4 27262-47-1 92253
11
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
12
Ondansetron Approved Phase 4 99614-02-5 4595
13
chenodeoxycholic acid Approved Phase 4 474-25-9 10133
14
Remifentanil Approved Phase 4 132875-61-7 60815
15
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
16
Granisetron Approved, Investigational Phase 4 109889-09-0 3510
17
Bupivacaine Approved, Investigational Phase 4 2180-92-9, 38396-39-3 2474
18
Tramadol Approved, Investigational Phase 4 27203-92-5 33741
19
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
20
Neostigmine Approved, Vet_approved Phase 4 59-99-4 4456
21
Ephedrine Approved Phase 4 299-42-3 9294
22
Atropine Approved, Vet_approved Phase 4 51-55-8, 5908-99-6 174174
23
Morphine Approved, Investigational Phase 4 57-27-2 5288826
24
Pseudoephedrine Approved Phase 4 90-82-4 7028
25
Ketorolac Approved Phase 4 66635-83-4, 74103-06-3 3826
26
Esmolol Approved Phase 4 103598-03-4, 81147-92-4 59768
27
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
28
Ampicillin Approved, Vet_approved Phase 4 69-53-4 6249
29
Sultamicillin Approved, Investigational Phase 4 76497-13-7
30
Sulbactam Approved Phase 4 68373-14-8
31
Ursodeoxycholic acid Approved, Investigational Phase 4 128-13-2 31401
32
Aspartic acid Approved, Nutraceutical Phase 4 56-84-8 5960
33
Tauroursodeoxycholic acid Experimental, Investigational Phase 4 14605-22-2 12443252
34
Taurochenodeoxycholic acid Experimental Phase 4 516-35-8 387316
35 Flurbiprofen axetil Investigational Phase 4 91503-79-6
36 Antiviral Agents Phase 4
37 Excitatory Amino Acid Antagonists Phase 4
38 Anesthetics, Dissociative Phase 4
39 Antidepressive Agents Phase 4
40 Anticonvulsants Phase 4
41 Antimanic Agents Phase 4
42 Excitatory Amino Acids Phase 4
43 Dopamine D2 Receptor Antagonists Phase 4
44 Dopamine Antagonists Phase 4
45 Dopamine Agents Phase 4
46 Anesthetics, Local Phase 4
47 Central Nervous System Depressants Phase 4
48 Anti-Anxiety Agents Phase 4
49 Tranquilizing Agents Phase 4
50 Neurotransmitter Agents Phase 4

Interventional clinical trials:

(show top 50) (show all 158)
# Name Status NCT ID Phase Drugs
1 The Discovery of the Double Sphincter in Gallbladder Unknown status NCT01998451 Phase 4 Tauroursodeoxycholic acid
2 Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy Unknown status NCT00209885 Phase 4 Gabapentin;S-ketamine;Lidocaine;Droperidol
3 Randomised Controlled Trail of Warmed Humidified Insufflation Versus Cold Non-Humidified Insufflation in Elective Laparoscopic Cholecystectomies: Does This Reduce Post-Operative Pain? Unknown status NCT00792389 Phase 4
4 Closed-Loop Target Controlled Infusion of Propofol and Remifentanil Guided by Narcotrend Index in Laparoscopic Cholecystectomy Unknown status NCT02114437 Phase 4
5 DOLCE Study: Day-care Versus Overnight-stay Laparoscopic Cholecystectomy Randomized, Controlled Trial Unknown status NCT01052727 Phase 4
6 Effects of Calot's Triangle Block for Postoperative Analgesia in Patients Undergoing Laparoscopic Cholecystectomy: a Prospective, Randomized, Double-blind, Controlled, Clinical Trial Unknown status NCT02300480 Phase 4
7 Laparo-endoscopic Single Site Cholecystectomy Versus Standard Laparoscopic Cholecystectomy Unknown status NCT01339325 Phase 4
8 Effects of Intraperitoneal Levobupivacaine on Pain After Laparoscopic Cholecystectomy: A Prospective, Randomized, Double-Blinded Study Completed NCT00836316 Phase 4 levobupivacaine
9 Combined Preincisional Infiltration and Intraperitoneal Instillation of Levobupivacaine for Postoperative Pain Reduction After Laparoscopic Cholecystectomy; A Double-blind Placebo-controlled Randomised Clinical Trial Completed NCT01199406 Phase 4 Levobupivacaine
10 Effect of Acupuncture on Postoperative Nausea and Vomiting Completed NCT00674713 Phase 4 Ondansetron;Physiological saline solution;Ondansetron;Physiological saline solution
11 Study of Oxidative Stress in Standard Laparoscopic vs Single Port Cholecystectomy for Uncomplicated Cholelithiasis (Lap vs SILS) Completed NCT01211743 Phase 4
12 Robotic Assisted Versus Laparoscopic Cholecystectomy - Completed NCT00562900 Phase 4
13 Laparoscopic Guided Regional Analgesia (LaGRA) Reduces Post Operative Pain After Laparoscopic Cholecystectomy - a Randomised, Controlled Trial. Completed NCT03394807 Phase 4 Levobupivacaine;Placebo
14 Changes in Bile Acid Homeostasis and Stool Habits After Cholecystectomy Completed NCT03168555 Phase 4 chenodeoxycholic acid
15 Studie Naar De Effectiviteit Van Ursodeoxycholzuur Ter Preventie Van Galsteen-Gerelateerde Klachten Bij patiënten in Afwachting Van Een Cholecystectomie Completed NCT00161083 Phase 4 ursodeoxycholic acid
16 Dual-Loop Target Controlled Infusion of Propofol and Remifentanil Guided by Narcotrend Index in Laparoscopic Cholecystectomy Completed NCT02116985 Phase 4
17 Cholecystocholangiography Versus Cystic Duct Cholangiography During Laparoscopic Cholecystectomy: A Prospective Controlled Randomized Trial Completed NCT01103570 Phase 4
18 Effect of Endovenous Lidocaine on Analgesia and Serum Cytokines Concentration: Randomized and Double-blind Trial Completed NCT02363699 Phase 4 Lidocaine;Saline solution
19 Granisetron Effect on Hemodynamic Changes and Intubation Condition During Anesthesia Induction in Laparoscopic Cholecystectomy Completed NCT03180229 Phase 4 Granisetron 1 Mg/mL Intravenous Solution
20 Minilaparoscopic Versus Conventional Laparoscopic Cholecystectomy: A Randomized Trial Completed NCT01397565 Phase 4
21 Intraoperative Lidocaine Infusion vs. Esmolol Infusion for Postoperative Analgesia in Laparoscopic Cholecystectomy: a Randomized Clinical Trial Completed NCT02327923 Phase 4 Lidocaine;Esmolol;Paracetamol;Lidocaine;Propofol;Fentanyl;Vecuronium;Atropine;Ephedrine;Morphine;Ketorolac;Ondansetron;Bupivacaine;Tramadol;Neostigmine;Glycopyrrolate
22 Multi-Port vs. Single-port Cholecystectomy Completed NCT01104727 Phase 4
23 All the Phases Study Will be Operated by the Department of Hepatobiliary Surgery, The Affiliated Hospital of Guiyang Medical College Recruiting NCT01822262 Phase 4
24 Ciprofloxacin, Ampicillin-sulbactam and Placebo Prophylaxis in Laparoscopic Cholecystectomy. A Randomized Controlled Study Suspended NCT01888822 Phase 4 Ciprofloxacin;Ampicillin-sulbactam;Placebo
25 Biliary Lithotripsy in Combination With Actigall Versus Actigall Monotherapy for the Treatment of Symptomatic Cholesterol Gallstones Terminated NCT00042549 Phase 4 ursodiol
26 The Role of Ursodeoxycholic Acid in Treatment of Gallstones in Hemolytic Disorders Terminated NCT02472509 Phase 4 Ursodeoxycholic Acid
27 Use of IV Acetaminophen Intraoperatively in Obese Patients at Risk for Obstructive Sleep Apnea Undergoing Laparoscopic Cholecystectomy Withdrawn NCT02056678 Phase 4 acetaminophen, IV preparation
28 Single Port Access Cholecystectomy Versus Standard Laparoscopic Cholecystectomy - Randomized Study Unknown status NCT00904865 Phase 2, Phase 3
29 Effectiveness of Ursodeoxycholic Acid Use in the Prevention of Gallstone Formation After Sleeve Gastrectomy: A Prospective Randomized Multicenter Placebo-Controlled Trial Unknown status NCT02721862 Phase 3 Ursodeoxycholic Acid;Placebo
30 Efficacy and Safety of Renalof Administration in the Treatment of Elderly Patients With Gallstones Completed NCT01099319 Phase 3
31 Combined Sphincterotomy and Balloon Dilation (ESBD) Versus Standard Sphincterotomy (ES) in Removing Biliary Stones—a Randomized Controlled Trial Completed NCT00164853 Phase 3
32 Prospective Randomized Clinical Trial Comparing Laparoscopic Cholecystectomy and Hybrid Natural Orifice Translumenal Endoscopic Surgery (NOTES) Completed NCT00835250 Phase 3
33 An Expertise-based Randomized Controlled Trial Comparing Minilaparotomy Cholecystectomy and Laparoscopic Cholecystectomy Completed NCT00370344 Phase 2, Phase 3
34 Prospective Randomized Clinical Trial Comparing Single Incision Laparoscopic Surgery vs Flexible Single Incision Surgery on Cholecystectomy Completed NCT01558414 Phase 3
35 Treatment of Suspected Cholelithiasis With Nitroglycerin: a Randomized, Prospective Double-blind Trial Unknown status NCT01715220 Phase 2 sublingual nitroglycerine
36 Effects of Obeticholic Acid on Hepatic Fatty Acid/Triglyceride Metabolism and Hepatobiliary Detoxification/Elimination in Morbidly Obese and Gallstone Patients Completed NCT01625026 Phase 2 Obeticholic acid;Placebo
37 Transvaginal Natural Orifice Translumenal and Endoscopic Surgery (NOTES) Cholecystectomy vs. Laparoscopic Cholecystectomy: Phase I/II Clinical Trial Completed NCT00710502 Phase 1, Phase 2
38 Natural Orifice Translumenal Endoscopic Surgery: Laparoscopic-Assisted Transvaginal Cholecystectomy Terminated NCT00910325 Phase 1, Phase 2
39 Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study Terminated NCT02325492 Phase 2 Aramchol;Placebo
40 Single Incision Laparoscopic Cholecystectomy Completed NCT00678873 Phase 1
41 Laparoscopic Cholecystectomy Using Transvaginal Endoscopic Assistance Withdrawn NCT00815438 Phase 1
42 Comparison of Single Trocar Cholecystectomy to Standard Laparoscopic Cholecystectomy Unknown status NCT00732550
43 Clinical Application of Cholangiojejunostomy in the Surgical Treatment of Cholelithiasis With Moderate Dilatation of Common Bile Duct Unknown status NCT02915770
44 Randomised Non-inferiority Trial of Laparoscopic Cholecystectomy Performed With EndoCone Single Port Versus Conventional Multi-port Laparoscopic Approach Using Clinical, PROMS and Health Economic Endpoints Unknown status NCT01709877
45 Three-dimensional High-definition (3DHD) Laparoscopy Versus Two-dimensional High-definition (2DHD) Laparoscopy in Cholecystectomy: a Clinical Controlled Randomized Double Blinded Trial. Unknown status NCT02396927
46 Cosmesis and Body Image After Single Port Laparoscopic or Conventional Laparoscopic Cholecystectomy: A Double Blinded Randomised Controlled Trial Unknown status NCT01278472
47 Probiotics for Gallstones in Post-bariatric Surgery Patients:A Prospective Unknown status NCT03247101 Miyarisan-BM (Clostridium Butyricum Miyairi);Urso group;Biotase group
48 Clinical Study of Abdominal Drainage in Laparoscopic Common Bile Duct Exploration With Primary Closure Unknown status NCT03120754
49 Proficiency-based Versus Free Laparoscopic Training in Cholecystectomy Using the Simbionix LAP Mentor™. A Randomized Controlled Trial Unknown status NCT01615549
50 Effect of Vitamin C on Postoperative Pain After Laparoscopic Cholecystectomy; a A Prospective Randomized Controlled Trial Unknown status NCT02553551 Vitamin C;Placebo

Search NIH Clinical Center for Cholecystolithiasis

Cochrane evidence based reviews: cholecystolithiasis

Genetic Tests for Cholecystolithiasis

Anatomical Context for Cholecystolithiasis

MalaCards organs/tissues related to Cholecystolithiasis:

40
Pancreas, Liver, Skin, Colon, Testes, Lymph Node, Heart

Publications for Cholecystolithiasis

Articles related to Cholecystolithiasis:

(show top 50) (show all 895)
# Title Authors PMID Year
1
Transgastric endoscopic gallbladder polypectomy and cholecystolithiasis: A case report. 61
31853277 2020
2
Clinical Efficacy Analysis of the Combination of the Laparoscope and Preoperative or Intraoperative Duodenoscope in the Treatment of Cholecystolithiasis with Choledocholithiasis: A Retrospective Study. 61
31647359 2019
3
Laparoscopic cholecystectomy for cholecystolithiasis with Dubin-Johnson syndrome. 61
31832555 2019
4
Gallstone formation due to rapid weight loss through hyperthyroidism. 61
31730531 2019
5
TJP2 hepatobiliary disorders: Novel variants and clinical diversity. 61
31696999 2019
6
Early-stage T1b adenocarcinoma arising in the remnant cystic duct after laparoscopic cholecystectomy: a case report and literature review. 61
31783817 2019
7
Non-obstetric surgery during pregnancy - an eleven-year retrospective analysis. 61
31653246 2019
8
Bile Duct Stones Predict a Requirement for Cholecystectomy in Older Patients. 61
31654201 2019
9
True single-port cholecystectomy with ICG cholangiography through a single 15-mm trocar using the new surgical platform "symphonX": first human case study with a commercially available device. 61
31659506 2019
10
Role of gallbladder-preserving surgery in the treatment of gallstone diseases in young and middle-aged patients in China: results of a 10-year prospective study. 61
31606197 2019
11
Endoscopic mucosal resection of a bile duct polyp: A case report. 61
31616704 2019
12
Characteristics of amino acid profile and incretin hormones in patients with gallstone disease - a pilot study. 61
31553330 2019
13
Inferior pancreaticoduodenal artery pseudoaneurysm in a patient with calculous cholecystitis: A case report. 61
31616702 2019
14
Prevalence of dyspepsia in patients with cholecystolithiasis: a systematic review and meta-analysis. 61
31206407 2019
15
Laparoscopic transcystic common bile duct exploration and laparoscopic transductal common bile duct exploration in elderly patients with cholecystolithiasis combined with choledocholithiasis. 61
31261208 2019
16
Needleless Transcutaneous Neuromodulation Accelerates Postoperative Recovery Mediated via Autonomic and Immuno-Cytokine Mechanisms in Patients With Cholecystolithiasis. 61
30277014 2019
17
Comorbidities Associated with Large Abdominal Aortic Aneurysms. 61
31805597 2019
18
PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway. 61
31182136 2019
19
Clinical analysis of prophylactic cholecystectomy during gastrectomy for gastric cancer patients: a retrospective study of 1753 patients. 61
31088424 2019
20
[Diagnosis and treatment for unexpected gallbladder carcinoma(a retrospective study of 45 cases)]. 61
30929371 2019
21
[Differential diagnosis of gallbladder abnormalities : Ultrasound, computed tomography, and magnetic resonance imaging]. 61
30789997 2019
22
Hem-o-lok clip found in the common bile duct 3 years after laparoscopic cholecystectomy and surgical exploration. 61
30616484 2019
23
Single-Stage Endoscopic Stone Extraction and Cholecystectomy during the Same Hospitalization. 61
30300983 2019
24
Combination of serum gamma-glutamyltransferase and alkaline phosphatase in predicting the diagnosis of asymptomatic choledocholithiasis secondary to cholecystolithiasis. 61
30705891 2019
25
Clonorchiasis sinensis detected by laparoscopic exploration of biliary tracts in two patients with obstructive jaundice. 61
30621611 2019
26
Myotonic Dystrophy-2: Unusual Phenotype Due to a Small CCTG-expansion. 61
30984523 2018
27
Hemolytic jaundice induced by pharmacological dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency: A case report. 61
30572463 2018
28
A new perspective on perioperative coagulation management in a patient with congenital factor VII deficiency: A case report. 61
30383632 2018
29
Statistical analysis plan of a randomized controlled trial to compare a restrictive strategy to usual care for the effectiveness of cholecystectomy (SECURE trial). 61
30390706 2018
30
[Minimally invasive robot-assisted gastric bypass after open Mason reduction gastroplasty]. 61
30135966 2018
31
Axillo-Axillary Artery Bypass With Coil Embolization of the Innominate Artery for a Traumatic Innominate Artery Aneurysm: A Case Report. 61
29807496 2018
32
Learning curve for performing choledochotomy bile duct exploration with primary closure after laparoscopic cholecystectomy. 61
29602995 2018
33
Distribution of the ATP-binding cassette transporter ABCG8 IVS1-2A>G genotype and clinical characteristics of gallbladder patients in Northeastern Mexico: A pilot study. 61
30271604 2018
34
Sarcomatous intrahepatic cholangiocarcinoma: Case report and literature review. 61
30278551 2018
35
Pseudo-Wellens' syndrome and intermittent left bundle branch block in acute cholecystitis. 61
29661666 2018
36
Transvaginal Hybrid NOTES Cholecystectomy: A Single-Centre Long-Term Experience on Sexual Function. 61
29270655 2018
37
A 0.8-cm clear cell neuroendocrine tumor G1 of the gallbladder with lymph node metastasis: a case report. 61
30037336 2018
38
Cavernous Transformation of the Portal Vein Secondary to Cholecystolithiasis. 61
29786056 2018
39
Intraoperative cholangiography during cholecystectomy in sequential treatment of cholecystocholedocholithiasis: To be, or not to be, that is the question A cohort study. 61
29555524 2018
40
Risk assessment of choledocholithiasis prior to laparoscopic cholecystectomy and its management options. 61
29774157 2018
41
Telomere length of gallbladder epithelium is shortened in patients with congenital biliary dilatation: measurement by quantitative fluorescence in situ hybridization. 61
29143121 2018
42
[Transcystic biliary drainage versus nasobiliary drainage during primary closure of the laparoscopic choledochotomy]. 61
29397627 2018
43
Laparoscopic cholecystectomy with aberrant bile duct detected by intraoperative fluorescent cholangiography concomitant with angiography: A case report. 61
30130667 2018
44
Laparoscopic cholecystectomy in patient with situs viscerum inversus totalis and gallbladder empyema - a case report. 61
30590932 2018
45
Gallbladder agenesis: A case report and review of the literature. 61
30428439 2018
46
Pathogenesis of gallbladder adenomyomatosis and its relationship with early-stage gallbladder carcinoma: an overview. 61
29791592 2018
47
[A Case of Port Site Recurrence of Gallbladder Carcinoma after Laparoscopic Cholecystectomy]. 61
29362315 2018
48
Free Intraperitoneal Gallstone: An Unusual Case of Small Bowel Obstruction from Extrinsic Compression. 61
29535884 2018
49
Acute cholecystitis - a cohort study in a real-world clinical setting (REWO study, NCT02796443). 61
30498388 2018
50
Acceptance of Ambulatory Laparoscopic Cholecystectomy in Central Switzerland. 61
28660320 2017

Variations for Cholecystolithiasis

Expression for Cholecystolithiasis

Search GEO for disease gene expression data for Cholecystolithiasis.

Pathways for Cholecystolithiasis

Pathways related to Cholecystolithiasis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.39 TGFB1 CCN2 BMP6
2 10.99 TGFB1 CCN2 BMP6

GO Terms for Cholecystolithiasis

Biological processes related to Cholecystolithiasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 positive regulation of gene expression GO:0010628 9.71 TGFB1 CRP CCN2 BMP6
2 positive regulation of collagen biosynthetic process GO:0032967 9.43 TGFB1 CCN2
3 positive regulation of superoxide anion generation GO:0032930 9.37 TGFB1 CRP
4 receptor catabolic process GO:0032801 9.32 UVRAG TGFB1
5 positive regulation of SMAD protein signal transduction GO:0060391 9.26 TGFB1 BMP6
6 positive regulation of vascular permeability GO:0043117 9.16 TGFB1 BMP6
7 positive regulation of peptidyl-tyrosine phosphorylation GO:0050731 9.13 TGFB1 CCK BMP6
8 connective tissue development GO:0061448 8.62 TGFB1 CCN2

Molecular functions related to Cholecystolithiasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 growth factor activity GO:0008083 8.8 TGFB1 CCN2 BMP6

Sources for Cholecystolithiasis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....